As of 2025-05-29, the EV/EBITDA ratio of Diagnos Inc (ADK.V) is -8.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ADK.V's latest enterprise value is 27.15 mil CAD. ADK.V's TTM EBITDA according to its financial statements is -3.04 mil CAD. Dividing these 2 quantities gives us the above ADK.V EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 12.0x | 8.2x |
| Forward P/E multiples | 10.3x - 14.8x | 14.6x |
| Fair Price | (0.34) - (0.39) | (0.37) |
| Upside | -244.1% - -265.5% | -258.4% |
| Date | EV/EBITDA |
| 2025-05-22 | -9.26 |
| 2025-05-21 | -8.42 |
| 2025-05-20 | -8.76 |
| 2025-05-16 | -9.09 |
| 2025-05-15 | -8.92 |
| 2025-05-14 | -9.26 |
| 2025-05-13 | -9.43 |
| 2025-05-12 | -9.09 |
| 2025-05-09 | -9.43 |
| 2025-05-08 | -9.09 |
| 2025-05-07 | -9.09 |
| 2025-05-06 | -9.26 |
| 2025-05-05 | -9.43 |
| 2025-05-02 | -9.43 |
| 2025-05-01 | -9.43 |
| 2025-04-30 | -9.26 |
| 2025-04-29 | -9.26 |
| 2025-04-28 | -9.26 |
| 2025-04-25 | -9.59 |
| 2025-04-24 | -9.59 |
| 2025-04-23 | -9.76 |
| 2025-04-22 | -9.76 |
| 2025-04-21 | -9.76 |
| 2025-04-17 | -9.09 |
| 2025-04-16 | -9.43 |
| 2025-04-15 | -9.76 |
| 2025-04-14 | -9.76 |
| 2025-04-11 | -10.09 |
| 2025-04-10 | -10.26 |
| 2025-04-09 | -10.09 |
| 2025-04-08 | -9.76 |
| 2025-04-07 | -10.09 |
| 2025-04-04 | -10.09 |
| 2025-04-03 | -10.09 |
| 2025-04-02 | -10.43 |
| 2025-04-01 | -10.43 |
| 2025-03-31 | -11.10 |
| 2025-03-28 | -10.43 |
| 2025-03-27 | -10.43 |
| 2025-03-26 | -10.76 |
| 2025-03-25 | -10.76 |
| 2025-03-24 | -10.93 |
| 2025-03-21 | -10.26 |
| 2025-03-20 | -10.76 |
| 2025-03-19 | -11.10 |
| 2025-03-18 | -10.76 |
| 2025-03-17 | -11.27 |
| 2025-03-14 | -11.43 |
| 2025-03-13 | -11.52 |
| 2025-03-12 | -11.60 |